© 2020 MJH Life Sciences and Neurology Live. All rights reserved.
© 2020 MJH Life Sciences™ and Neurology Live. All rights reserved.
November 30, 2020
Here's what is coming soon to NeurologyLive.
November 29, 2020
Two experts in neuro-ophthalmology discuss the advances in the identification
and treatment of patients presenting with optic neuritis.
November 28, 2020
Guest editor-in-chief Darin T. Okuda, MD, FAAN, FANA, details the fast moving field of multiple sclerosis and the direction the disease is moving towards in 2021.
November 27, 2020
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending November 27, 2020.
The chair of the department of neurology at The Ohio State University spoke to the ongoing conversation in MS about how aggressive to be with treatment early on.
“Is more always better?”: The age-old question is more relevant than ever as clinicians and patients alike navigate an increasingly crowded MS treatment landscape.
Stephen Krieger, MD from the Icahn School of Medicine at Mount Sinai spoke about the phase 3 trial of nabiximols he will be investigating in MS.
November 26, 2020
Effectively navigating the nuances of this unique patient population will ultimately help drive innovative solutions for this generation and those to come.
November 25, 2020
As the adoption of telemedicine rises, the ability to incorporate digital and telehealth-based therapies offers clinicians a unique opportunity to supplement the comprehensive care model.
November 24, 2020
Advanced imaging technology collides with artificial intelligence in what is shaping up to be a revolutionary period for the diagnosis and management of MS.
Experts in multiple sclerosis review top data presented at the 8th joint ACTRIMS-ECTRIMS meeting.
November 23, 2020